| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90694307P | 2007-03-13 | 2007-03-13 |
| Publication Number | Publication Date |
|---|---|
| PE20081880A1true PE20081880A1 (es) | 2008-12-31 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008000451APE20081880A1 (es) | 2007-03-13 | 2008-03-11 | Mutaciones de k-ras y terapia con anticuerpos anti-egfr |
| Country | Link |
|---|---|
| US (3) | US20080293055A1 (es) |
| EP (2) | EP2121989B2 (es) |
| JP (1) | JP2010521153A (es) |
| AR (1) | AR065687A1 (es) |
| AU (1) | AU2008226803A1 (es) |
| CA (1) | CA2680326A1 (es) |
| CL (1) | CL2008000717A1 (es) |
| CY (2) | CY1115333T1 (es) |
| DK (2) | DK2121989T4 (es) |
| ES (2) | ES2458626T5 (es) |
| HR (2) | HRP20140360T4 (es) |
| HU (1) | HUE033695T2 (es) |
| LT (1) | LT2465950T (es) |
| MX (1) | MX2009009787A (es) |
| PE (1) | PE20081880A1 (es) |
| PL (2) | PL2121989T5 (es) |
| PT (2) | PT2121989E (es) |
| RS (2) | RS56422B1 (es) |
| SI (2) | SI2121989T2 (es) |
| TW (1) | TW200902553A (es) |
| WO (1) | WO2008112269A2 (es) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1917528B1 (en)* | 2005-08-24 | 2011-08-17 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| JP2009537154A (ja) | 2006-05-18 | 2009-10-29 | モレキュラー プロファイリング インスティテュート， インコーポレイテッド | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
| US8768629B2 (en) | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
| EP2118322A2 (en)* | 2007-03-13 | 2009-11-18 | Amgen Inc. | K-ras and b-raf mutations and anti-egfr antibody therapy |
| WO2010028288A2 (en) | 2008-09-05 | 2010-03-11 | Aueon, Inc. | Methods for stratifying and annotating cancer drug treatment options |
| GB2463401B (en) | 2008-11-12 | 2014-01-29 | Caris Life Sciences Luxembourg Holdings S A R L | Characterizing prostate disorders by analysis of microvesicles |
| US8502015B1 (en) | 2009-07-06 | 2013-08-06 | Transgenex Nanobiotech, Inc. | Method of inducing cancer |
| CN102115782B (zh)* | 2009-12-30 | 2014-06-18 | 北京雅康博生物科技有限公司 | 用于定量检测K-ras突变的试剂盒 |
| US9128101B2 (en) | 2010-03-01 | 2015-09-08 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
| US9469876B2 (en) | 2010-04-06 | 2016-10-18 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers for metastatic prostate cancer |
| KR20120140252A (ko)* | 2010-04-12 | 2012-12-28 | 리스판스 지네틱스, 인크. | Ｋｒａｓ 프라이머 및 프로브 |
| AU2011305445B2 (en) | 2010-09-24 | 2017-03-16 | The Board Of Trustees Of The Leland Stanford Junior University | Direct capture, amplification and sequencing of target DNA using immobilized primers |
| SG194111A1 (en) | 2011-04-07 | 2013-11-29 | Amgen Inc | Novel egfr binding proteins |
| US9920373B2 (en) | 2011-11-11 | 2018-03-20 | Millennium Pharmaceuticals, Inc. | Biomarkers of response to proteasome inhibitors |
| US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| ES2906714T3 (es) | 2012-09-04 | 2022-04-20 | Guardant Health Inc | Métodos para detectar mutaciones raras y variación en el número de copias |
| US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US20140199405A1 (en)* | 2013-01-11 | 2014-07-17 | Abraxis Bioscience, Llc | Method for treating cancer based on mutation status of k-ras |
| WO2014148557A1 (ja)* | 2013-03-19 | 2014-09-25 | 凸版印刷株式会社 | Ｅｇｆｒ阻害剤感受性予測方法 |
| ES2784450T3 (es) | 2013-12-28 | 2020-09-25 | Guardant Health Inc | Métodos y sistemas para detectar variantes genéticas |
| ES2844229T3 (es)* | 2014-05-13 | 2021-07-21 | Univ Texas | Mutaciones génicas y alteraciones en el número de copias de EGFR, KRAS y MET |
| CA3008651A1 (en) | 2015-12-17 | 2017-06-22 | Guardant Health, Inc. | Methods to determine tumor gene copy number by analysis of cell-free dna |
| SG11202012653XA (en) | 2018-06-19 | 2021-01-28 | Biontech Us Inc | Neoantigens and uses thereof |
| CN110357965A (zh)* | 2019-06-24 | 2019-10-22 | 浙江大学 | 一种突变型kras特异性抗体及其制备方法 |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| US5151510A (en) | 1990-04-20 | 1992-09-29 | Applied Biosystems, Inc. | Method of synethesizing sulfurized oligonucleotide analogs |
| US6407213B1 (en) | 1991-06-14 | 2002-06-18 | Genentech, Inc. | Method for making humanized antibodies |
| ATE173767T1 (de) | 1992-04-03 | 1998-12-15 | Perkin Elmer Corp | Proben zusammensetzung und verfahren |
| US5470705A (en) | 1992-04-03 | 1995-11-28 | Applied Biosystems, Inc. | Probe composition containing a binding domain and polymer chain and methods of use |
| KR100643058B1 (ko) | 1996-12-03 | 2006-11-13 | 아브게닉스, 인크. | 복수의 Ｖн 및 Ｖк 영역을 함유하는 인간 면역글로불린 유전자좌를 갖는 트랜스제닉 포유동물 및 이로부터 생성된 항체 |
| US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| CA2365125A1 (en) | 1999-03-15 | 2000-09-21 | Paul D. Grossman | Probe/mobility modifier complexes for multiplex nucleic acid detection |
| JP2004507226A (ja) | 2000-05-30 | 2004-03-11 | ピーイー コーポレイション （エヌワイ） | ライゲーションおよび増幅の組み合わせを用いて標的核酸を検出するための方法 |
| US6503914B1 (en)* | 2000-10-23 | 2003-01-07 | Board Of Regents, The University Of Texas System | Thienopyrimidine-based inhibitors of the Src family |
| EP1575491A4 (en) | 2002-05-20 | 2006-09-27 | Abgenix Inc | TREATMENT OF RENAL CARCINOMA USING ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR |
| EP2226396A1 (en) | 2003-05-30 | 2010-09-08 | Genomic Health, Inc. | Gene expression markers for response to EGFR inhibitor drugs |
| CN101501211A (zh) | 2004-03-31 | 2009-08-05 | 综合医院公司 | 测定癌症对表皮生长因子受体靶向性治疗反应性的方法 |
| AU2005250484B2 (en) | 2004-06-04 | 2011-08-11 | Genentech, Inc. | EGFR mutations |
| WO2006047484A2 (en)* | 2004-10-22 | 2006-05-04 | Redpath Integrated Pathology, Inc. | Molecular analysis of cellular fluid and liquid cytology specimens for clinical diagnosis, characterization, and integration with microscopic pathology evaluation |
| CN102007220A (zh) | 2005-04-01 | 2011-04-06 | 安姆根有限公司 | 表皮生长因子受体基因拷贝数 |
| EP1869208A1 (en)* | 2005-04-14 | 2007-12-26 | Merck Patent GmbH | Anti-egfr antibody therapy based on an increased copy number of the egfr gene in tumor tissues |
| SI1913157T2 (sl)* | 2005-06-28 | 2017-02-28 | Genentech, Inc. | EGFR in KRAS mutacije za napoved bolnikovega odziva na zdravljenje z EGFR inhibitorjem |
| WO2007011702A2 (en)* | 2005-07-15 | 2007-01-25 | The University Of North Carolina At Chapel Hill | Use of egfr inhibitors to prevent or treat obesity |
| EP1917528B1 (en)* | 2005-08-24 | 2011-08-17 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| WO2007109571A2 (en)* | 2006-03-17 | 2007-09-27 | Prometheus Laboratories, Inc. | Methods of predicting and monitoring tyrosine kinase inhibitor therapy |
| US8293501B2 (en)* | 2006-09-12 | 2012-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for performing low background multiplex nucleic acid amplification reactions |
| EP2118322A2 (en)* | 2007-03-13 | 2009-11-18 | Amgen Inc. | K-ras and b-raf mutations and anti-egfr antibody therapy |
| Publication | Publication Date | Title |
|---|---|---|
| PE20081880A1 (es) | Mutaciones de k-ras y terapia con anticuerpos anti-egfr | |
| PE20090690A1 (es) | Mutaciones de k-ras y b-raf y terapia con anticuerpos anti-egfr | |
| NZ591137A (en) | Methods and systems for predicting response of cells to a therapeutic agent | |
| MY185858A (en) | Specific binding proteins and uses thereof | |
| WO2008021183A3 (en) | For the identification, assessment, and treatment of patients with cancer therapy | |
| WO2013182912A3 (en) | Method for the diagnosis, prognosis and treatment of lung cancer metastasis | |
| BRPI0418745A (pt) | anticorpo linhagem de células, composição farmacêutica, e, método de tratamento de cáncer em um paciente | |
| IL209854A (en) | Polypeptide, an amino acid sequence encoded for this polypeptide, and the use of this polypeptide for the preparation of a cancer suppressant | |
| HK1213946A1 (zh) | 用於使用c-maf对前列腺癌转移进行诊断、预後和治疗的方法 | |
| WO2012083302A3 (en) | Compositions and methods for the treatment or prevention of human adenovirus-36 infection | |
| BR112012012912A2 (pt) | anticorpo ou fragmento do mesmo, ácido nucleico, vetor, célula hospedeira, método para a produção de um anticorpo ou um fragmento do mesmo, composição farmacêutica, método para tratar ou prevenir uma condição médica em um indivíduo, uso de um anticorpo ou fragmento do mesmo e métodos in vitro para neutralizar il-10 em uma amostra e para detectar a presença de il-10 em uma amostra. | |
| WO2004113571A3 (en) | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis | |
| MX353964B (es) | Agentes terapeuticos y usos de los mismos. | |
| NZ706420A (en) | Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors | |
| MX2009012271A (es) | Compuestos antagonistas de acido ribonucleico para la modulacion de her3. | |
| EP2274437A4 (en) | COMPOSITIONS AND METHODS FOR DETECTION OF EGFR MUTATIONS IN CASES OF CANCER | |
| WO2006014159A3 (en) | Methods of using regenerative cells in the treatment of musculoskeletal disorders | |
| NZ609567A (en) | Markers of endothelial progenitor cells and uses thereof | |
| NZ592911A (en) | Leukolectins and uses thereof | |
| DE602004031782D1 (de) | Verfahren zur verwendung regenerativer zellen zur förderung der wundheilung | |
| NZ735720A (en) | Anti-vegfr2 human antibody for anti-angiogenic and targeted cancer therapy | |
| EP1461449A4 (en) | SYSTEM FOR MONITORING THE TREATMENT OF A BACTERIAL TUMOR | |
| ATE514718T1 (de) | Peptabody für krebsbehandlung | |
| WO2006022612A3 (en) | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders | |
| WO2012109233A3 (en) | Methods for predicting recurrence risk in breast cancer patients |
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |